Women’s knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID‑19 era in a sample of them: COMEM‑GSM study Baquedano Mainar, Laura Mendoza Ladrón De Guevara, Nicolás COMEM Study Spanish investigators Genitourinary syndrome of menopause Knowledge Menopause COVID-19 Confinement Adherence The surveys have been carried out by the COMEM Study Spanish investigators in the following hospitals: Hospital Universitario Miguel Servet of Zaragoza, Hospital San Jorge of Huesca, Hospital Universitario La Zarzuela of Madrid, Hospital San Carlos of San Fernando, Hospital Insular-Materno Infantil of Las Palmas, Hospital Quirón Salud of Zaragoza, Hospital Clínico San Carlos of Madrid, Hospital Universitario of Castellón, Complejo Hospitalario of Jaén, Hospital Universitario Central of Asturias, Clínica Diatros of Barcelona, Instituto Palacios of Madrid and European Institute of Sexology, Marbella. The team of seven menopause experts who made the survey was made up of: L Baquedano, P Coronado, N Mendoza, I Ramirez, E de la Viuda, B Otero and S Sánchez. Objective: To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement. Methods: Multi-center observational study including women between 35 and 75 years. An extension study of treatment adherence was conducted during the coronavirus pandemic between March and April 2020. Results: A sample of 2355 women were included. Vaginal dryness was the most frequently identified symptom (74.3%). Lubricants were the best-known treatments (69.6%), followed by local estrogens (25.7%); 66% of the women did not speak to their gynecologist about sexuality. Comparative analyses were conducted according to age, menopausal status, type of menopause, place of residence, type of health care received and level of education. During the coronavirus confinement period, adherence to treatments for vulvovaginal atrophy was poor in 72.5% asked (n = 204). Reduced sexual activity (p > 0.001) and coronavirus diagnosis (p = 0.003) were significantly associated with poorer treatment compliance. Conclusions: There is great lack of knowledge of the treatments used for GSM. Most women do not talk to their gynecologist about sexuality. Adherence to treatments during the coronavirus confinement has been worryingly low. 2021-12-16T11:55:34Z 2021-12-16T11:55:34Z 2021-11-30 journal article Baquedano Mainar, L... [et al.]. Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study. BMC Women's Health 21, 398 (2021). [https://doi.org/10.1186/s12905-021-01548-2] http://hdl.handle.net/10481/72090 10.1186/s12905-021-01548-2 eng http://creativecommons.org/licenses/by/3.0/es/ open access Atribución 3.0 España BMC